News Room

Prescient thought leaders are available to comment on a variety of healthcare and industry-related topics. For more information or to connect to a subject matter expert or thought leader, please contact info@prescienthg.com.
In the News

Prescient Healthcare Group Strengthens Its US Leadership Team

Posted on 07/16/2018

Prescient appoints Dr. Paul Harney as President, North America. LONDON, July 17, 2018—Prescient Healthcare Group, a biopharmaceutical product and portfolio strategy firm, announces the recent appointment of Dr. Paul Harney as President, North America. He has also been named to Prescient’s Board of Directors. Paul joins Prescient after spending more than 20 years providing [...] Read More

 

Twitter Feed

Our research among #competitiveintelligence stakeholders throughout #biopharma identified the top CI challenges. We highlight strategic imperatives and actionable recommendations to face these challenges head-on. Read more: https://t.co/Cfhtqe7rIe #TurningScienceIntoValue

Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team

Prescient announces the recent appointment of three new senior members to its Intelligence & Insight business: Jeanne Penn, Ben Kebble and Dr. Mladen Tomich. They join the existing Intelligence & Insight team, shaping the competitive strategy of Prescient’s clients through enhanced decision support.

2020 Biocom Global Life Sciences Partnering Conference

The 2020 Biocom Global Life Sciences Partnering Conference will be held from February 25-27, 2020 in La Jolla, California. The event is an exclusive partnering forum that provides senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies around the globe to network and conduct business.

Manuscript: Mechanosensitive Ca2+ signaling and coordination is diminished in osteocytes of aged mice during ex vivo tibial loading

This work used a novel ex vivo model to demonstrate diminished mechanosensing and lack of signaling coordination in aged osteocyte networks in live bone, which may contribute to pathology of age-induced bone loss.

Manuscript: AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis

The American Society of Gene and Cell Therapy has accepted and published a manuscript from Prescient’s Carly Jones in Molecular Therapy

LeadingBiotech – East/West CEO 2020 (San Francisco)

LeadingBiotech’s East/West CEO will be held during January 11-12, 2020, in San Francisco. The event brings together global leaders in the biopharma community to network and share insights on the industry outlook for the year ahead. Dr. Mark Little and Dr. Julia Seaman will be attending the event on behalf of Prescient.

2019 ASBMR Young Investigator Award

Prescient’s Andrea Campi has been recognized with the ASBMR Young Investigator Award. The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established to bring together clinical and experimental scientists who are involved in the study of bone and mineral metabolism.

2019 Pharma CiMi.CON USA

The 2019 annual Pharma CiMi.CON will be held on November 7-8 in Boston. Dr. Mark Little will attend this event on behalf of Prescient. The event will bring together more than 120 competitive and market intelligence professionals for networking and exchange, to discuss key industry topics and to create new partnerships.

2019 New Product Planning (NPP) Summit

Prescient will be in Boston, MA, for the 2019 New Product Planning Summit on December 2-3, 2019. On December 2 at 9:00 AM, Prescient will lead a podium session on:

Biocom Q4 2019 Deal Makers Reception

The Biocom Q4 2019 Deal Makers Reception Awards will be held on Thursday, December 12, in La Jolla, California. Biocom is an exclusive networking group made up of representatives from the biotech space, academia, research institutions and venture capital firms who are interested in discussing key trends and news with other industry leaders. Dr. Paul Harney and Dr. Debasish Talukdar will attend the event on behalf of Prescient.

2019 FierceBiotech Drug Development Forum

The 2019 FierceBiotech Drug Development Forum will be held on October 28-29, 2019, in Boston. Dr. Mark Little will attend the event on behalf of Prescient. The event will feature insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies addressing the strategic and operational challenges in product development strategy and deal-making and business strategy.